EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Imaging Cardiac Amyloidosis: From Early Diagnosis to Risk Stratification and Evaluation of Treatment Efficacy

Matteo Sclafani iD, Domitilla Russo, Georgios Oikonomou, Giovanni Camastra iD, Emanuela Belmonte, Giacomo Tini, Rossella Rotunno, Cristina Chimenti iD, Chiara Lanzillo, Beatrice Musumeci iD, Teresa Castiello, Stefano Regondi und 3 weitere

Journal of Cardiovascular Development and Disease · 21.08.2026 · 13 (8) · 401

DOI: 10.3390/jcdd13080401 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 21.08.2026. Verfasst von Matteo Sclafani und 14 weiteren Autor:innen. Beteiligte Einrichtung: Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London SW3 6PY, UK. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy caused by extracellular deposition of misfolded proteins, most commonly immunoglobulin light chains (AL) or transthyretin (ATTR). Once considered a rare disease, CA is increasingly recognised due to improved diagnostic strategies and the availability of disease-modifying therapies. Early diagnosis is crucial, as treatment efficacy and clinical outcomes are strongly influenced by the stage of cardiac involvement. Multimodality cardiac imaging plays a central role in the diagnostic pathway, risk stratification, and evaluation of therapeutic response in CA. Echocardiography represents the first-line imaging modality and is essential for raising clinical suspicion through the identification of characteristic structural and functional abnormalities, including ventricular wall thickening, diastolic dysfunction, and distinctive strain patterns. Bone scintigraphy has revolutionised the non-invasive diagnosis of ATTR-CA, allowing accurate identification of transthyretin-related disease in the absence of monoclonal gammopathy, which needs to be excluded via serum and urinary immunofixation. Cardiovascular magnetic resonance provides advanced tissue characterisation through late gadolinium enhancement and quantitative mapping techniques, enabling detection of early myocardial involvement and robust prognostic stratification. Emerging imaging modalities, including dual-energy (spectral) computed tomography and positron emission tomography tracers, show promise in myocardial amyloid quantification and subtype differentiation, although their role is still evolving. Integration of imaging findings with clinical and laboratory parameters allows comprehensive disease assessment, facilitating early diagnosis, guiding therapeutic decisions, and improving risk stratification. This review summarises the current role of multimodality imaging in CA, highlighting its contribution from early detection to prognostic evaluation and monitoring of treatment efficacy, with particular emphasis on the emerging role of quantitative imaging in monitoring treatment response.

Schlagwörter

Stichwörter der Autor:innen

T1 mappingbone scintigraphycardiac amyloidosiscardiac computed tomographycardiac magnetic resonance imagingechocardiography

Autor:innen und Institutionen

  • Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London SW3 6PY, UK.
  • Cardiology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University, 00189 Rome, Italy.
  • UOC Cardiology, Santo Spirito Hospital, 00193 Rome, Italy.
  • Hellenic Heart Foundation (ELIKAR), 115 21 Athens, Greece.
  • Cardiology Unit, Madre Giuseppina Vannini Hospital, 00177 Rome, Italy.
  • Department of Medical and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy.

ORCID-Profile: Matteo Sclafani, Giovanni Camastra, Cristina Chimenti, Beatrice Musumeci, Luca Cacciotti, Luca Arcari

Zitieren

APA

Sclafani, M., Russo, D., Oikonomou, G., Camastra, G., Belmonte, E., Tini, G., Rotunno, R., Chimenti, C., Lanzillo, C., Musumeci, B., Castiello, T., Regondi, S., Ricci, R., Cacciotti, L., & Arcari, L. (2026). Imaging Cardiac Amyloidosis: From Early Diagnosis to Risk Stratification and Evaluation of Treatment Efficacy. Journal of Cardiovascular Development and Disease, 13(8), 401. https://doi.org/10.3390/jcdd13080401

Vancouver

Sclafani M, Russo D, Oikonomou G, Camastra G, Belmonte E, Tini G, et al. Imaging Cardiac Amyloidosis: From Early Diagnosis to Risk Stratification and Evaluation of Treatment Efficacy. Journal of Cardiovascular Development and Disease. 2026;13(8):401. doi:10.3390/jcdd13080401

BibTeX
@article{Sclafani2026,
  author = {Sclafani, Matteo and Russo, Domitilla and Oikonomou, Georgios and Camastra, Giovanni and Belmonte, Emanuela and Tini, Giacomo and Rotunno, Rossella and Chimenti, Cristina and Lanzillo, Chiara and Musumeci, Beatrice and Castiello, Teresa and Regondi, Stefano and Ricci, Roberto and Cacciotti, Luca and Arcari, Luca},
  title = {Imaging Cardiac Amyloidosis: From Early Diagnosis to Risk Stratification and Evaluation of Treatment Efficacy},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2026},
  volume = {13},
  number = {8},
  pages = {401},
  doi = {10.3390/jcdd13080401}
}
Kostenlos starten →